PE html>
<html lang="en">
<head>
<meta charset="UTF-8">
<title>Quinidine Crystals Spike Walker (2006)</title>
<style>
    body {
        font-family: Arial, sans-serif;
        margin: 40px;
        display: flex;
    }
    img {
        max-width: 30%;
        height: 100%;
        margin-right: 20px;
    }
    .content {
        max-width: 70%;
    }
</style>
</head>
<body>
<img src="../images/QuinidineCrystalsSpikeWalker2006artofmedbook.jpg" alt="Quinidine Crystals Spike Walker (2006)">
<div class="content">
<p>[a] Artist/ Group/Tribe</p>
<p>Spike Walker is a British photomicrographer renowned for rendering scientific specimens with aesthetic force through polarized light microscopy. In this work, Quinidine Crystals (2006), Walker photographs the recrystallized alkaloid to expose fern-like dendritic forms and iridescent interference colors. The artist’s role is both documentarian and image-maker: he choreographs light, optics, and crystallization to translate molecular order into visual drama, aligning microscopy’s descriptive aim with a painterly sensibility.</p>

<p>[b] Historical and Socio-Cultural context (time-frame)</p>
<p>Quinidine is a stereoisomer of quinine, derived from the bark of cinchona trees known to Indigenous Andean communities and transmitted to Europe in the 17th century as “Jesuit’s bark.” Its global circulation was entangled with colonial extraction, plantation cultivation in Java and elsewhere, and the medicalization of empire through malaria control. By the 20th century, quinidine became a class Ia antiarrhythmic, linking the drug to cardiology as well as parasitology. In 2006, when this image was made, photomicrography had matured into a cross-disciplinary genre showcased in competitions and museum programs, celebrating the aesthetics of scientific imagery and the public communication of biomedicine.</p>

<p>[c] Symbolism and/ or iconography</p>
<p>The feathered fans and curling blades evoke ferns, frost, and plumage—natural motifs historically used to symbolize vitality, growth, and the branching networks of life. Here, those metaphors double as a portrait of cardiac conduction: the radiating leaflets resemble Purkinje fibers spreading depolarization through ventricular myocardium. The shimmering interference colors suggest shifting physiological states—the precarious oscillation between therapeutic rhythm and arrhythmic chaos. The crystalline whorls can also be read as vectors of colonial trade and knowledge transfer, their directional growth recalling routes of botanical smuggling and pharmaceutical circulation.</p>

<p>[d] Stylistic Significance (elements of art/ principles of design)</p>
<p>Walker exploits the birefringence of quinidine under crossed polarizers to generate saturated, complementary hues. Line is paramount: serrated edges and rhythmic repetitions produce a sense of velocity and torsion. Movement arises from sweeping S-curves and fan shapes that guide the eye across the field. Value contrast between luminous yellows and deep cyans sculpts depth in an otherwise flat plane. The composition balances order and contingency; dendritic symmetry is interrupted by micro-faults and turbulent folds, a visual analogue to the delicate margin between stable conduction and proarrhythmia.</p>

<p>[e] Social / Cultural Inequities</p>
<p>Cinchona’s history embodies asymmetries of power: Indigenous expertise was appropriated; colonial plantations centralized supply and profits abroad. In the present, antiarrhythmic therapy such as quinidine demands ECG monitoring, electrolyte management, and drug–drug interaction surveillance—resources unevenly distributed across health systems. Malaria, historically treated with quinine/quinidine, still exacts disproportionate burdens in low-income regions. Thus the same molecule that signifies cure also indexes structural disparities in research investment, access to care, and pharmacovigilance.</p>

<p>[f] Description of Disease & Etiology</p>
<p>Clinically, quinidine targets cardiac arrhythmias by blocking fast inward sodium channels (class Ia) and delaying repolarization via IKr potassium current inhibition, thereby prolonging action potential duration and the QT interval. Historically, it also served as an antimalarial by interfering with heme detoxification in Plasmodium parasites. Cardiac arrhythmias treated with quinidine include certain atrial and ventricular tachyarrhythmias, and in select contexts, Brugada syndrome or short QT syndrome where Ito/IKr modulation is beneficial. Its dual identity—antimalarial and antiarrhythmic—situates the compound at a junction of infectious disease and electrophysiology.</p>

<p>[g] Pathology Signs/Signifiers of Illness</p>
<p>Arrhythmias manifest as palpitations, syncope, dyspnea, or sudden cardiac arrest. Electrocardiography may reveal widened QRS with class Ia agents, prolonged QT, and in adverse scenarios, torsades de pointes. Toxicity, termed cinchonism, presents with tinnitus, headache, nausea, and visual disturbances; thrombocytopenia and hemolysis (notably with G6PD deficiency) may occur. In malaria, pathology is marked by periodic fevers, anemia, hemolysis, hypoglycemia, and in severe cases cerebral involvement; microscopy or rapid tests confirm parasitemia. Walker’s radiating crystal blades metaphorically mirror spiky ECG morphologies and fever spikes.</p>

<p>[h] Treatment</p>
<p>Quinidine’s therapeutic use requires careful selection, baseline and serial ECGs, and correction of hypokalemia or hypomagnesemia. Avoidance with congenital long QT or interacting QT-prolonging agents is essential. Torsades is managed with intravenous magnesium, overdrive pacing, or isoproterenol, and withdrawal of the offending drug. In malaria, intravenous artesunate has largely replaced quinidine for severe disease; supportive care includes glucose monitoring and treatment of anemia and organ dysfunction.</p>

<p>[i] Social Determinants of Illness</p>
<p>Vector ecology, housing, and climate shape malaria risk; poverty limits prevention (bed nets, indoor residual spraying) and timely therapy. For arrhythmias, determinants include access to screening, ECG telemetry, emergency response, and comprehensive medication review. Polypharmacy, supply interruptions, and limited laboratory capacity heighten adverse-event risk. These factors influence who benefits safely from quinidine and who faces disproportionate hazard.</p>

<p>[j] References and Citations</p>
<p>
- World Health Organization. Guidelines for malaria. https://www.who.int/publications/i/item/guidelines-for-malaria<br>
- CDC. Malaria Diagnosis & Treatment. https://www.cdc.gov/malaria/diagnosis_treatment/index.html<br>
- StatPearls. Quinidine. https://www.ncbi.nlm.nih.gov/books/NBK542294/<br>
- Belhassen B, et al. Management of Brugada syndrome with quinidine. Heart Rhythm. 2004. https://pubmed.ncbi.nlm.nih.gov/15171969/<br>
- Science History Institute. Quinine and the story of cinchona. https://www.sciencehistory.org/topics/quinine<br>
- Nikon MicroscopyU. Introduction to Polarized Light Microscopy. https://www.microscopyu.com/techniques/polarized-light/introduction<br>
- DrugBank. Quinidine (DB00945). https://go.drugbank.com/drugs/DB00945<br>
- Nikon Small World. Quinidine crystals photomicrograph. https://www.nikonsmallworld.com/<br>
- Bhatt S, et al. The effect of malaria control on Plasmodium falciparum in Africa, 2000–2015. Nature. 2015. https://www.nature.com/articles/nature15535
</p>
</div>
</body>
</ht